- Corporate Officers - H
- Hershberg Robert
Insider Trading History of Hershberg Robert
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hershberg Robert since 2020.
This trader's CIK number is 1274139.
At the time of last reporting, Hershberg Robert was the Director of Adaptive Biotechnologies Corp. (stock ticker symbol ADPT).
Also see all insider trading activities at Adaptive Biotechnologies Corp.
Note that in the past
HERSHBERG ROBERT also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Nanostring Technologies Inc (NSTG) by Hershberg Robert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | NSTG | 0 | $0 | 0 | $0 | 3,306 | $0 |
| 2021 | NSTG | 0 | $0 | 4,188 | $304,651 | 4,188 | $46,905 |
| 2020 | NSTG | 0 | $0 | 20,668 | $770,504 | 22,558 | $195,738 |
Yearly summary of insider trading at Fate Therapeutics Inc (FATE) by Hershberg Robert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | FATE | 0 | $0 | 672 | $15,288 | 0 | $0 |
Yearly summary of insider trading at Hillevax, Inc. (HLVX) by Hershberg Robert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | HLVX | 0 | $0 | 26,535 | $48,663 | 0 | $0 |
| 2024 | HLVX | 0 | $0 | 11,597 | $173,166 | 0 | $0 |
Yearly summary of insider trading at Adaptive Biotechnologies Corp (ADPT) by Hershberg Robert
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ADPT | 0 | $0 | 53,000 | $402,270 | 0 | $0 |
| 2023 | ADPT | 0 | $0 | 0 | $0 | 53,000 | $23,850 |
| 2021 | ADPT | 0 | $0 | 8,000 | $442,530 | 8,000 | $3,600 |
| 2020 | ADPT | 0 | $0 | 41,000 | $1,464,904 | 41,000 | $18,450 |
Insider trading activities at 4 companies by Hershberg Robert:
1. Nanostring Technologies Inc (NSTG)
2. Fate Therapeutics Inc (FATE)
3. Hillevax, Inc. (HLVX)
4. Adaptive Biotechnologies Corp (ADPT)
Table 1. Insider trading of Nanostring Technologies Inc (NSTG) by Hershberg Robert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-04-18 | NSTG | Option Ex | 3,306 | .00 | 0 |
| 2021-03-15 | NSTG | Sale | 1,500 | 65.59 | 98,385 |
| 2021-03-15 | NSTG | Option Ex | 1,500 | 11.20 | 16,800 |
| 2021-02-16 | NSTG | Option Ex | 1,188 | 11.20 | 13,305 |
| 2021-02-16 | NSTG | Sale | 1,188 | 81.17 | 96,432 |
| 2021-01-15 | NSTG | Sale | 1,500 | 73.22 | 109,834 |
| 2021-01-15 | NSTG | Option Ex | 1,500 | 11.20 | 16,800 |
| 2020-12-15 | NSTG | Option Ex | 1,500 | 11.20 | 16,800 |
| 2020-12-15 | NSTG | Sale | 1,500 | 69.28 | 103,920 |
| 2020-11-16 | NSTG | Option Ex | 1,500 | 11.20 | 16,800 |
| 2020-11-16 | NSTG | Sale | 1,500 | 46.67 | 70,005 |
| 2020-10-15 | NSTG | Option Ex | 1,500 | 11.20 | 16,800 |
| 2020-10-15 | NSTG | Sale | 1,500 | 39.23 | 58,852 |
| 2020-09-15 | NSTG | Option Ex | 1,500 | 11.20 | 16,800 |
| 2020-09-15 | NSTG | Sale | 1,500 | 43.88 | 65,812 |
| 2020-08-17 | NSTG | Option Ex | 1,500 | 11.20 | 16,800 |
| 2020-08-17 | NSTG | Sale | 1,500 | 38.47 | 57,705 |
| 2020-07-15 | NSTG | Sale | 1,500 | 35.85 | 53,782 |
| 2020-07-15 | NSTG | Option Ex | 1,500 | 11.20 | 16,800 |
| 2020-06-15 | NSTG | Option Ex | 3,390 | 5.60 | 18,984 |
| 2020-06-15 | NSTG | Sale | 1,500 | 30.79 | 46,186 |
| 2020-05-15 | NSTG | Sale | 10,168 | 30.91 | 314,242 |
| 2020-05-15 | NSTG | Option Ex | 10,168 | 7.47 | 75,954 |
Table 2. Insider trading of Fate Therapeutics Inc (FATE) by Hershberg Robert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-03 | FATE | Sale | 672 | 22.75 | 15,288 |
Table 3. Insider trading of Hillevax, Inc. (HLVX) by Hershberg Robert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-04 | HLVX | Sale | 14,634 | 1.89 | 27,658 |
| 2025-02-11 | HLVX | Sale | 11,901 | 1.76 | 21,005 |
| 2024-02-08 | HLVX | Sale | 11,597 | 14.93 | 173,166 |
Table 4. Insider trading of Adaptive Biotechnologies Corp (ADPT) by Hershberg Robert
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-12 | ADPT | Sale | 53,000 | 7.59 | 402,270 |
| 2023-02-02 | ADPT | Option Ex | 53,000 | .45 | 23,850 |
| 2021-03-08 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2021-03-08 | ADPT | Sale | 2,000 | 44.56 | 89,120 |
| 2021-03-08 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2021-03-08 | ADPT | Sale | 2,000 | 44.56 | 89,120 |
| 2021-02-16 | ADPT | Sale | 2,000 | 65.45 | 130,900 |
| 2021-02-16 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2021-01-15 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2021-01-15 | ADPT | Sale | 2,000 | 66.69 | 133,390 |
| 2020-12-15 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2020-12-15 | ADPT | Sale | 2,000 | 56.40 | 112,790 |
| 2020-11-16 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2020-11-16 | ADPT | Sale | 2,000 | 48.01 | 96,010 |
| 2020-10-15 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2020-10-15 | ADPT | Sale | 2,000 | 51.51 | 103,020 |
| 2020-09-15 | ADPT | Sale | 2,000 | 42.58 | 85,160 |
| 2020-09-15 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2020-08-17 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2020-08-17 | ADPT | Sale | 2,000 | 39.59 | 79,170 |
| 2020-07-15 | ADPT | Sale | 2,000 | 44.09 | 88,180 |
| 2020-07-15 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2020-06-15 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2020-06-15 | ADPT | Sale | 2,000 | 43.01 | 86,010 |
| 2020-05-15 | ADPT | Sale | 2,000 | 35.16 | 70,314 |
| 2020-05-15 | ADPT | Option Ex | 2,000 | .45 | 900 |
| 2020-04-23 | ADPT | Option Ex | 25,000 | .45 | 11,250 |
| 2020-04-23 | ADPT | Sale | 25,000 | 29.77 | 744,250 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hershberg Robert
(Director of Adaptive Biotechnologies Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.